Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APALUTAMIDE for Hormone-dependent prostate cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 533 adverse event reports in the FDA FAERS database where APALUTAMIDE was used for Hormone-dependent prostate cancer.

Most Reported Side Effects for APALUTAMIDE

Side Effect Reports % Deaths Hosp.
Rash 1,117 11.7% 47 225
Death 1,008 10.6% 991 45
Fatigue 824 8.6% 21 106
Hot flush 532 5.6% 12 61
Product dose omission issue 384 4.0% 1 24
Diarrhoea 317 3.3% 6 64
Asthenia 303 3.2% 13 67
Dizziness 294 3.1% 7 38
Fall 268 2.8% 20 133
Off label use 257 2.7% 32 44
Decreased appetite 255 2.7% 17 83
Arthralgia 253 2.7% 3 36
Prostatic specific antigen increased 251 2.6% 11 37
Pruritus 224 2.4% 5 59
Hospitalisation 209 2.2% 5 202

Other Indications for APALUTAMIDE

Product used for unknown indication (4,070) Prostate cancer (3,286) Prostate cancer metastatic (659) Hormone-refractory prostate cancer (365) Neoplasm malignant (48) Prostate cancer stage 0 (25) Metastases to bone (17) Neoplasm prostate (17) Prostate cancer stage iv (13) Prostatic specific antigen increased (11)

Other Drugs Used for Hormone-dependent prostate cancer

DAROLUTAMIDE (294) ENZALUTAMIDE (289) ABIRATERONE (236) DEGARELIX (187) LEUPROLIDE (181) DOCETAXEL (90) PREDNISONE (47) DOCETAXEL\DOCETAXEL ANHYDROUS (42) GALLIUM GA-OZETOTIDE (41) ZOLEDRONIC ACID (35)

Related Pages

APALUTAMIDE Full Profile All Hormone-dependent prostate cancer Drugs APALUTAMIDE Demographics APALUTAMIDE Timeline